Should You Invest In Illumina?

Illumina Inc. is a global biotechnology company headquartered in San Diego, California. The company has a strong focus on DNA research, and its sequencing and array technologies support a broad range of ground-breaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. The company was founded in 1998, and operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. The firm’s is a leading producer of next-generation sequencing tools used primarily to isolate and analyse genes, and its customers include pharmaceutical and biotech companies, research centres, and academic institutions. The firm has regularly grown via strategic acquisitions that support its core activities. The company has acquired BlueBee, a cloud computing company whose capabilities will lower the cost of storing, sharing, and managing the data that the Illumina sequencing systems produce. The firm has also acquired Enancio, providing it with fast and efficient genomic data compression technology that complements other Illumina informatics solutions. The firm is listed on the NASDAQ where it trades under the stock ticker ILMN. Feel free to add this company to your watchlist here on eToro to get regular news and instant updates on changes to the ILMN price chart.